Trial intelligence / Profile preview

Effect of bezafibrate on cholestatic itch in primary biliary cholangitis

2014-001438-27Phase 2Active

Sponsor
Academic Medical Center
Start
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of bezafibrate in primary biliary cholangitis (PBC) and cholestatic disease, sponsored by Academic Medical Center. Primary endpoint: Primary endpoint: itch intensity reduction. Started Jul 2015; status: active.

02

Drugs

bezafibrate
03

Conditions

primary biliary cholangitis (PBC)cholestatic disease

Beyond the preview

Go deeper on 2014-001438-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-001438-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call